News in brief

New oral treatment for hyperkalaemia

4 October 2017, 10:59am

Osteoporosis treatment discontinued

1 September 2017, 10:50am

Methotrexate pen approved to treat Crohn's disease

7 August 2017, 10:19am

Preservative-free timolol eye drops available in multi-dose bottle

26 May 2017, 5:08pm

Once-daily modified-release oxycodone launched

2 May 2017, 12:06pm

Rituximab biosimilar launched in UK

3 April 2017, 4:07pm

New myeloma treatment provides all-oral regimen option

15 March 2017, 9:01am

Metronidazole caution in Cockayne syndrome

21 February 2017, 2:02pm

Etelcalcetide: a new treatment option for hyperparathyroidism

7 February 2017, 9:57am

Exjade: improved bioavailability for new presentation

1 February 2017, 12:43pm

NICE endorses use of sofosbuvir-velpatasvir in chronic hepatitis C

26 January 2017, 11:49am

Ibrutinib gains NICE approval for use in CLL

26 January 2017, 11:17am

New nebulised tobramycin product launched

10 January 2017, 1:28pm

Dalbavancin: new single-dose antibiotic for acute skin infections

3 January 2017, 12:10pm

Ticagrelor approved for NHS use post-MI

3 January 2017, 11:55am

NICE revises its decision on dapagliflozin in triple therapy

23 November 2016, 10:43am

Change of manufacturer for topical erectile dysfunction drug

11 November 2016, 9:13am

Lenvatinib launched for kidney cancer

12 October 2016, 2:53pm

New cabozantinib preparation for kidney cancer

12 October 2016, 11:55am

New aprepitant suspension for use in children

3 October 2016, 11:54am

Prescription spacer now available with 'whistling' mask to help children master technique

16 September 2016, 8:13am

Abatacept: a new option in active and progressive RA

13 September 2016, 10:48am

Movicol now available in ready-to-use sachets

1 September 2016, 9:15am

Cervarix approved to prevent anal cancer

25 August 2016, 10:52am

New oral fosfomycin preparation for uncomplicated UTI

23 August 2016, 9:21am

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter